#1 Clinical Trials Search in Europe

Bilastine

Bilastine is an antihistamine medication that has been the subject of numerous clinical trials investigating its use in various allergic conditions. These trials have explored different formulations, dosages, and applications of bilastine, ranging from oral tablets to ophthalmic solutions. The studies have focused on assessing the drug’s efficacy, safety, and tolerability in treating conditions such as allergic rhinitis, urticaria, and allergic conjunctivitis across different age groups.

Table of Contents

What is Bilastine?

Bilastine is a medication used to treat allergic conditions. It belongs to a class of drugs called antihistamines, which work by blocking the effects of histamine, a substance in the body that causes allergic symptoms. Bilastine is also known by other names such as Bilaxten, Alektos, and Robilas[7][6].

This medication is considered a second-generation antihistamine, which means it is less likely to cause drowsiness compared to older antihistamines. Bilastine is designed to provide relief from allergy symptoms without significantly affecting a person’s daily activities[8].

Conditions Treated by Bilastine

Bilastine is used to treat several allergic conditions, including:

  • Allergic Rhinitis: This condition, also known as hay fever, causes symptoms like sneezing, runny nose, and itchy eyes due to allergens in the air[7].
  • Allergic Conjunctivitis: An inflammation of the eye caused by an allergic reaction, leading to red, itchy, and watery eyes[3].
  • Chronic Urticaria: A condition characterized by recurring hives (itchy, raised welts on the skin) that can last for several weeks or months[4].
  • Cold Contact Urticaria: A specific type of urticaria where hives develop after exposure to cold temperatures[2].

Dosage Forms and Administration

Bilastine is available in several forms:

  • Oral Tablets: The most common form, typically available as 20 mg tablets for adults and adolescents[1].
  • Dispersible Oral Tablets: These are tablets that dissolve in the mouth, often used for children[6].
  • Ophthalmic Solution: Eye drops containing bilastine, used for treating allergic conjunctivitis[3].

The dosage and administration method depend on the patient’s age, the condition being treated, and the specific formulation. For adults, the typical dose is 20 mg once daily, while children may receive lower doses based on their weight and age[6].

Effectiveness of Bilastine

Clinical trials have shown that bilastine is effective in treating various allergic conditions:

  • In patients with allergic rhinitis, bilastine has been shown to improve quality of life and reduce symptoms such as sneezing, itching, and nasal congestion[7].
  • For chronic urticaria, bilastine has demonstrated effectiveness in reducing itching and the number of hives[4].
  • In cases of allergic conjunctivitis, bilastine eye drops have shown promise in reducing eye itching and redness[3].

Safety Profile and Side Effects

Bilastine is generally well-tolerated, with a safety profile similar to other second-generation antihistamines. Common side effects may include:

  • Headache
  • Drowsiness (although less common than with older antihistamines)
  • Fatigue
  • Dizziness

Studies have shown that bilastine does not significantly impair driving ability or cause severe drowsiness at recommended doses[8]. However, as with any medication, patients should be aware of how it affects them before operating machinery or driving.

Research has also been conducted to assess the cardiac safety of bilastine, particularly its effect on the heart’s electrical activity (QTc interval). At standard doses, bilastine does not appear to cause significant changes in heart rhythm[5].

Use in Special Populations

Bilastine has been studied in various populations:

  • Children: Specific formulations and dosages have been developed for children aged 2 to 12 years, with ongoing research to ensure safety and efficacy in this age group[6].
  • Elderly: While not specifically mentioned in the provided trials, antihistamines like bilastine are generally considered safe for older adults, but dosage adjustments may be necessary.
  • Pregnant and Breastfeeding Women: As with many medications, the safety of bilastine during pregnancy and breastfeeding should be discussed with a healthcare provider.

Ongoing Research and Future Directions

Research on bilastine is ongoing, with several areas of focus:

  • Development of new formulations, such as ophthalmic solutions for eye allergies[3].
  • Studies on higher doses for conditions like chronic urticaria that may not respond to standard doses[4].
  • Investigations into the long-term safety and efficacy of bilastine in various patient populations[9].
  • Comparisons with other antihistamines to establish its place in allergy treatment protocols[7].

As research continues, our understanding of bilastine’s benefits and potential uses may expand, potentially offering more treatment options for people with allergic conditions.

Aspect Details
Drug Forms Oral tablets, ophthalmic solutions
Dosages Studied Oral: 20 mg, 40 mg, 80 mg; Ophthalmic: 0.2%, 0.4%, 0.6%
Conditions Treated Allergic rhinitis, chronic urticaria, allergic conjunctivitis
Age Groups Adults, children (2 to 12 years)
Primary Outcomes Symptom reduction, quality of life, pharmacokinetics
Safety Assessments Adverse events, vital signs, ECG results
Comparison Studies Bilastine vs. loratadine, bilastine vs. placebo
Special Investigations Effects on driving performance, cardiac safety (QTc interval)

FAQ

  • What is bilastine and what conditions is it used to treat? Bilastine is an antihistamine medication used to treat allergic conditions. Clinical trials have investigated its use in allergic rhinitis, chronic urticaria (hives), and allergic conjunctivitis (eye allergies).
  • What forms of bilastine have been studied in clinical trials? Clinical trials have studied various forms of bilastine, including oral tablets, ophthalmic (eye) solutions, and different dosages ranging from 20 mg to 80 mg for oral use and 0.2% to 0.6% for eye drops.
  • Are there any studies on bilastine use in children? Yes, there have been clinical trials investigating the use of bilastine in children. For example, one study looked at the pharmacokinetics, safety, and tolerability of bilastine in children aged 2 to 12 years with allergic rhinoconjunctivitis or chronic urticaria.
  • What are some of the primary outcomes measured in bilastine clinical trials? Primary outcomes in bilastine trials have included measures of efficacy such as reduction in allergy symptoms, quality of life improvements, and pharmacokinetic parameters. Safety outcomes have included monitoring of adverse events, vital signs, and electrocardiogram (ECG) results.
  • Have any trials compared bilastine to other antihistamines? Yes, some trials have compared bilastine to other antihistamines. For instance, one study compared the quality of life in patients with allergic rhinitis treated with bilastine 20 mg versus those treated with loratadine 10 mg.

Ongoing Clinical Trials on Bilastine

  • Study of bilastine for effectiveness, safety and quality of life in children aged 6 to 12 years with allergic rhinoconjunctivitis

    Recruiting

    1 1 1 1
    Investigated drugs:
    Italy Poland Spain

  • Study comparing bilastine, ebastine, and desloratadine in preventing histamine-induced skin reactions in healthy volunteers

    Not recruiting

    1 1 1
    Investigated drugs:
    Spain

  • Study on the Effects of Mannan-Conjugated Birch Pollen Allergoids for Adolescents and Adults with Birch Pollen-Induced Allergic Rhinitis or Rhinoconjunctivitis

    Not recruiting

    1 1 1
    Investigated drugs:
    Germany

Glossary

  • Pharmacokinetics: The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.
  • Bioavailability: The proportion of a drug that enters the circulation when introduced into the body and is able to have an active effect.
  • Allergic rhinitis: An allergic inflammation of the nasal airways, commonly causing symptoms like sneezing, runny nose, and nasal congestion.
  • Chronic urticaria: A condition characterized by recurring hives (itchy, red welts on the skin) that last for more than six weeks.
  • Allergic conjunctivitis: An eye condition caused by an allergic reaction, resulting in red, itchy, and watery eyes.
  • QTc interval: A measure of the heart's electrical cycle, used to assess the risk of certain cardiac arrhythmias.
  • Placebo: An inactive substance or treatment used in clinical trials as a control to compare against the effects of the drug being tested.
  • Double-blind study: A type of clinical trial where neither the participants nor the researchers know who is receiving the actual treatment and who is receiving a placebo.
  • Crossover study: A type of clinical trial where participants receive different treatments in a specific order, allowing each participant to serve as their own control.
  • Adverse event: Any unfavorable and unintended sign, symptom, or disease temporarily associated with the use of a medical treatment or procedure.

References

  1. https://clinicaltrials.gov/study/NCT01124123
  2. https://clinicaltrials.gov/study/NCT01271075
  3. https://clinicaltrials.gov/study/NCT03231969
  4. https://clinicaltrials.gov/study/NCT02213367
  5. https://clinicaltrials.gov/study/NCT00419783
  6. https://clinicaltrials.gov/study/NCT01081574
  7. https://clinicaltrials.gov/study/NCT02513290
  8. https://clinicaltrials.gov/study/NCT02576041
  9. https://clinicaltrials.gov/study/NCT04810390